Avai Bio (AVAI) Non-Current Debt (2018 - 2023)

Avai Bio has disclosed Non-Current Debt across 4 years of filings, most recently posting $99000.0 for Q4 2023.

• Non-Current Debt for Q4 2023 came in at $99000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $99000.0 (changed N/A YoY), and the FY2023 annual result was $99000.0, changed N/A from the prior year.
• Non-Current Debt came in at $99000.0 for Q4 2023 at Avai Bio, roughly flat from $99000.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $99000.0 in Q1 2023 to a low of -$8361.0 in Q3 2019.
• The 3-year median for Non-Current Debt is -$280.0 (2020), against an average of $31433.2.
• Peak annual rise in Non-Current Debt reached 97.13% in 2020, while the deepest fall reached 97.13% in 2020.
• Avai Bio's Non-Current Debt stood at -$8361.0 in 2019, then jumped by 97.13% to -$240.0 in 2020, then jumped by 41350.0% to $99000.0 in 2023.
• The last three Non-Current Debt figures came in at $99000.0 (Q4 2023), $99000.0 (Q1 2023), and -$240.0 (Q3 2020), per Business Quant data.